Reaction Details |
| Report a problem with these data |
Target | Histamine H3 receptor |
---|
Ligand | BDBM50517523 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1869141 (CHEMBL4370207) |
---|
Ki | 1.9±n/a nM |
---|
Citation | Nirogi, R; Shinde, A; Mohammed, AR; Badange, RK; Reballi, V; Bandyala, TR; Saraf, SK; Bojja, K; Manchineella, S; Achanta, PK; Kandukuri, KK; Subramanian, R; Benade, V; Palacharla, RC; Jayarajan, P; Pandey, S; Jasti, V Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H J Med Chem62:1203-1217 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Histamine H3 receptor |
---|
Name: | Histamine H3 receptor |
Synonyms: | G-protein coupled receptor 97 | GPCR97 | HH3R | HISTAMINE H3 | HRH3 | HRH3_HUMAN | Histamine H3 receptor (H3) | Histamine H3L | Histamine receptor (H3 and H4) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 48691.47 |
Organism: | Homo sapiens (Human) |
Description: | Binding assays were using CHO cells stably expressing hH3R receptors. |
Residue: | 445 |
Sequence: | MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFV
ADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTS
SAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGG
SSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAA
GPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSV
ASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSL
AVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFR
RAFTKLLCPQKLKIQPHSSLEHCWK
|
|
|
BDBM50517523 |
---|
n/a |
---|
Name | BDBM50517523 |
Synonyms: | CHEMBL4518550 |
Type | Small organic molecule |
Emp. Form. | C22H35Cl2N3O2 |
Mol. Mass. | 444.438 |
SMILES | Cl.Cl.Cc1cc(OC2CCN(CC2)C2CCC2)ccc1NC(=O)CN1CCCC1 |
Structure |
|